“biogen” Archives

in
Entry Author Date Location
Biogen to Pay $1.25B to Settle Forward Pharma Patent Suit on MS Drug 01/17/17 Boston
Biotech Roundup: JPM Deals, Gender Diversity, PCSK9 Battle & More 01/13/17 National
Scangos Surfaces to Lead New Infectious Disease Startup, Vir Biotech 01/06/17 San Francisco
Families Fret As Insurers Mull Biogen’s $750K Spine Disease Drug 01/06/17 National
Varmus, Sato on Steering De Blasio’s $500M Plan to Grow NY Biotech 12/30/16 New York
Biogen Sets $750,000 Initial Price For First-Ever Spinal Atrophy Drug 12/28/16 Boston
Ionis, Biogen Make History With FDA Nod for Spine Disease Drug 12/23/16 Boston
Bio Roundup: Crazy ’16, Trials of ’17, Senate on Drugs & More 12/23/16 National
Biogen Promotes Vounatsos to CEO, Capping Scangos’s 6-Year Run 12/19/16 Boston
Bio Roundup: NY Rises, Prez Inks Cures, Ophthotech Crashes & More 12/16/16 National
NY Bio Surge Continues as De Blasio Unveils $500M, 10-Year Life Sci Plan 12/13/16 New York
Amyloid Hypothesis Lives On—Solanezumab, Too, Despite “Siren Song” 12/09/16 Indiana
Amyloid Hypothesis Takes a Hit As Lilly’s Alzheimer’s Drug Fails Again 11/23/16 Indiana
Bio Roundup: Trump’s Triumph, Election Fallout, CRISPR Arguments & More 11/11/16 National
Bio Roundup: Drug Pricing, Cystic Fibrosis Showdown, Myovant & More 10/28/16 National
With New Name and $47M, Proclara Begins First Big Alzheimer’s Test 09/07/16 Boston
Bio Roundup: RIP Roger Tsien, Novartis CAR-T Wheel, Zika News & More 09/02/16 National
Duchenne Lessons: Advocates For Rare Spinal Disease Have Eyes on FDA 08/26/16 National
In Wake Of Infamous Biotech Party, 20 Women Join New Exec Training 08/23/16 National
Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More 08/12/16 National
Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More 08/05/16 National
Pfizer Continues Gene Therapy Push With $150M Bamboo Buyout 08/01/16 Raleigh Durham
Biogen Buys Ionis Spine Disease Drug For $75M, Eyes FDA Filing 08/01/16 Boston
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
With Biogen at a Crossroads, CEO Scangos to Step Down 07/21/16 Boston
Biotech Roundup: Fighting Addiction, Obama Precision, Juno Deaths & More 07/08/16 National
Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More 07/01/16 National
Syros Cuts Price But Bags $50M in IPO to Fuel Cancer Drug Trials 06/29/16 Boston
Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More 06/10/16 National
Biogen’s Nerve Repair Drug Fails MS Study, Shares Fall 06/07/16 Boston
Page 1 of 5 next page »